# US 2020/0368150 A1 · Sensitization cream comprising l-arginine and l-citrulline and therapeutic uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0368150 A1
- Document ID: US20200368150A1
- Status: Published application
- Kind: A1
- Application number: 16/968,271
- Filed: 2019-02-07
- Published: 2020-11-26
- Earliest claimed: 2018-02-09
- Assignees: Innovus Pharmaceuticals, Inc.
- Applicants: Innovus Pharmaceuticals, Inc.
- Inventors: Bassam DAMAJ
- Web page: https://patentgrep.com/patent/US20200368150A1

## CPC

- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K 8/44: Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K 8/9789: Magnoliopsida [dicotyledons]
- A61K 9/0034: {Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 36/23: Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K 36/54: Lauraceae (Laurel family), e.g. cinnamon or sassafras
- A61K 36/736: Prunus, e.g. plum, cherry, peach, apricot or almond
- A61P 17/16: Emollients or protectives, e.g. against radiation
- A61Q 19/00: Preparations for care of the skin
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Topical compositions comprising L-arginine and L-citrulline are described. Methods and uses are also provided that include the administration of an effective amount of the topical compositions. The topical compositions are useful for increasing sensitization of the skin and/or for increasing blood flow to the skin.

## Claims

### Claim 1

A method for improving the sensitivity of the skin comprising applying to the skin an effective amount of a topical composition comprising sweet almond oil, cinnamon bark oil, coriander seed oil, L-arginine, and L-citrulline in an oil-in-water emulsion.

### Claim 2 (depends on 1)

The method of claim 1, wherein the composition is applied to the skin.

### Claim 3 (depends on 2)

The method of claim 2, wherein the skin is on the foot or hand.

### Claim 4 (depends on 3)

The method of claim 3, wherein the skin is on the penis.

### Claim 5 (depends on 4)

The method of claim 4, wherein the penis is circumcised or uncircumcised.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1 to 5, wherein the composition comprises: about 6 wt. % sweet almond oil, about 0.75 wt. % cinnamon bark oil, about 0.5 wt. % coriander seed oil, about from about 0.33 wt. % to about 3.0 wt. % L-arginine, and from about 0.67 wt. % to about 6.0 wt. % L-citrulline.

### Claim 7 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1 to 5, wherein the mass ratio of L-arginine to L-citrulline is about 1:2.

### Claim 8 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1 to 5, wherein the mass ratio of sweet almond oil to cinnamon bark oil to coriander seed oil to L-arginine to L-citrulline is about 72:9:6:4:8.

### Claim 9 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1 to 5, wherein the composition comprises: about 6 wt. % sweet almond oil, about 0.75 weight percent cinnamon bark oil, about 0.5 wt. % coriander seed oil, from about 0.34 to about 3.0 wt. % L-arginine, from about 0.68 to about 6.0 wt. % L-citrulline, about 5.0 wt. % of a 70 percent by weight sorbitol solution in water, about 4.0 wt. % of a 70 percent by weight isopropyl alcohol solution in water, about 20.0 wt. % propylene glycol, about 1.0 wt. % butylated hydroxytoluene, about 1.0 wt. % triethanolamine, about 1.0 wt. % benzyl alcohol, about 1.0 wt. % benzyl benzoate, about 3.5 wt. % PEG 40-hydrogenated castor oil, about 1.3 wt. % acrylate/C10-30 alkyl acrylate crosspolymer, about 0.1 wt. % ethylenediaminetetraacetic acid disodium salt, and the balance water.

### Claim 10 (depends on 1, 2, 3, 4, 5)

The method of any of claims 1 to 5, wherein a dose of about 0.5 mL to about 5 mL of the composition is applied to the skin from two to three times daily for a period of from two to three weeks, and from once to twice daily as needed thereafter.

### Claim 11

A method for improving blood flow to the skin comprising applying to the skin an effective amount of a topical composition comprising sweet almond oil, cinnamon bark oil, coriander seed oil, L-arginine, and L-citrulline in an oil-in-water emulsion.

### Claim 12 (depends on 11)

The method of claim 11, wherein the composition is applied to the skin.

### Claim 13 (depends on 12)

The method of claim 12, wherein the skin is on the foot or hand.

### Claim 14 (depends on 11)

The method of claim 11 wherein the skin is on the penis.

### Claim 15 (depends on 14)

The method of claim 14, wherein the penis is circumcised or uncircumcised.

### Claim 16 (depends on 11, 12, 13, 14, 15)

The method of any one of claims 11 to 15, wherein the composition comprises: about 6 wt. % sweet almond oil, about 0.75 wt. % cinnamon bark oil, about 0.5 wt. % coriander seed oil, from about 0.34 to about 3.0 wt. % L-arginine, and from about 0.68 to about 6.0 wt. % L-citrulline.

### Claim 17 (depends on 11, 12, 13, 14, 15)

The method of any one of claims 11 to 15, wherein the mass ratio of L-arginine to L-citrulline is about 1:2.

### Claim 18 (depends on 11, 12, 13, 14, 15)

The method of any one of claims 11 to 15, wherein the mass ratio of sweet almond oil to cinnamon bark oil to coriander seed oil to L-arginine to L-citrulline is about 72:9:6:4:8.

### Claim 19 (depends on 11, 12, 13, 14, 15)

The method of any one of claims 11 to 15, wherein the composition comprises: about 6 wt. % sweet almond oil, about 0.75 weight percent cinnamon bark oil, about 0.5 wt. % coriander seed oil, from about 0.34 to about 3.0 wt. % L-arginine, from about 0.68 to about 6.0 wt. % L-citrulline, about 5.0 wt. % of a 70 percent by weight sorbitol solution in water, about 4.0 wt. % of a 70 percent by weight isopropyl alcohol solution in water, about 20.0 wt. % propylene glycol, about 1.0 wt. % butylated hydroxytoluene, about 1.0 wt. % triethanolamine, about 1.0 wt. % benzyl alcohol, about 1.0 wt. % benzyl benzoate, about 3.5 wt. % PEG 40-hydrogenated castor oil, about 1.3 wt. % acrylate/C10-30 alkyl acrylate crosspolymer, about 0.1 wt. % ethylenediaminetetraacetic acid disodium salt, and the balance water.

### Claim 20 (depends on 11, 12, 13, 14, 15)

The method of any of claims 11 to 15, wherein a dose of from about 0.5 mL to about 5 mL of the composition is applied to the skin from two to three times daily for a period of from two to three weeks and from once to twice daily as needed thereafter.

### Claim 21

A method for treating neuropathy comprising applying to the skin an effective amount of a topical composition comprising sweet almond oil, cinnamon bark oil, coriander seed oil, L-arginine, and L-citrulline in an oil-in-water emulsion.

### Claim 22 (depends on 21)

The method of claim 21, wherein the composition is applied to the skin.

### Claim 23 (depends on 22)

The method of claim 22, wherein the skin is on the feet or hands.

### Claim 24

Tis applied to the skin from two to three times daily for a period of from two to three weeks and from once to twice daily as needed thereafter.

### Claim 25 (depends on 24)

The method of claim 24, wherein the penis is circumcised or uncircumcised.

### Claim 26 (depends on 21, 22, 23, 24)

The method of any one of claims 21 to 24, wherein the composition comprises: about 6 wt. % sweet almond oil, about 0.75 wt. % cinnamon bark oil, about 0.5 wt. % coriander seed oil, from about 0.34 to about 3.0 wt. % L-arginine, and from about 0.68 to about 6.0 wt. % L-citrulline.

### Claim 27 (depends on 21, 22, 23, 24)

The method of any one of claims 21 to 24, wherein the mass ratio of L-arginine to L-citrulline is about 1:2.

### Claim 28 (depends on 21, 22, 23, 24)

The method of any one of claims 21 to 24, wherein the mass ratio of sweet almond oil to cinnamon bark oil to coriander seed oil to L-arginine to L-citrulline is about 72:9:6:4:8.

### Claim 29 (depends on 21, 22, 23, 24)

The method of any one of claims 21 to 24, wherein the composition comprises: about 6 wt. % sweet almond oil, about 0.75 weight percent cinnamon bark oil, about 0.5 wt. % coriander seed oil, from about 0.34 wt. to about 3.0% L-arginine, from about 0.68 to about 6.0 wt. % L-citrulline, about 5.0 wt. % of a 70 percent by weight sorbitol solution in water, about 4.0 wt. % of a 70 percent by weight isopropyl alcohol solution in water, about 20.0 wt. % propylene glycol, about 1.0 wt. % butylated hydroxytoluene, about 1.0 wt. % triethanolamine, about 1.0 wt. % benzyl alcohol, about 1.0 wt. % benzyl benzoate, about 3.5 wt. % PEG 40-hydrogenated castor oil, about 1.3 wt. % acrylate/C10-30 alkyl acrylate crosspolymer, about 0.1 wt. % ethylenediaminetetraacetic acid disodium salt, and the balance water.

### Claim 30 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method of any of claims 21 to 29, wherein the dose of 0.5 to 5 mL of the composition are applied to the skin two to three times daily for a period of two to three weeks and once to twice daily as needed thereafter.

### Claim 31 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

The method of any of claims 21 to 30, wherein the neuropathy is diabetic neuropathy.

### Claim 32

A topical composition for improving blood flow to the skin and the sensitivity of the skin comprising sweet almond oil, cinnamon bark oil, coriander seed oil, L-arginine, and L-citrulline in an oil-in-water emulsion.

### Claim 33 (depends on 33)

The composition of claim 33, wherein the composition comprises: about 6 wt. % sweet almond oil, about 0.75 wt. % cinnamon bark oil, about 0.5 wt. % coriander seed oil, from about 0.34 to about 3.0 wt. % L-arginine, and from about 0.68 to about 6.0 wt. % L-citrulline.

### Claim 34 (depends on 32, 33)

The composition of any one of claims 32 to 33, wherein the mass ratio of L-arginine to L-citrulline is approximately 1:2.

### Claim 35 (depends on 32, 33)

The composition of any one of claims 32 to 33, wherein the mass ratio of sweet almond oil to cinnamon bark oil to coriander seed oil to L-arginine to L-citrulline is about 72:9:6:4:8.

### Claim 36 (depends on 32, 33)

The composition of any one of claims 32 to 33, further comprising one or more pharmaceutically acceptable excipients.

### Claim 37 (depends on 32, 33)

The composition of any one of claims 32 to 33, wherein the composition comprises: about 6 wt. % sweet almond oil, about 0.75 weight percent cinnamon bark oil, about 0.5 wt. % coriander seed oil, from about 0.34 to about 3.0 wt. % L-arginine, from about 0.68 to about 6.0 wt. % L-citrulline, about 5.0 wt. % of a 70 percent by weight sorbitol solution in water, about 4.0 wt. % of a 70 percent by weight isopropyl alcohol solution in water, about 20.0 wt. % propylene glycol, about 1.0 wt. % butylated hydroxytoluene, about 1.0 wt. % triethanolamine, about 1.0 wt. % benzyl alcohol, about 1.0 wt. % benzyl benzoate, about 3.5 wt. % PEG 40-hydrogenated castor oil, about 1.3 wt. % acrylate/C10-30 alkyl acrylate crosspolymer, about 0.1 wt. % ethylenediaminetetraacetic acid disodium salt, and the balance water.

### Claim 38 (depends on 26, 27)

The composition of any one of claims 26 to 27, wherein the composition comprises from about 150 mg to about 3.0 g L-arginine and from about 300 to about 3.0 g L-citrulline.
